aTyr Pharma | LIFE - Loan Capital


aTyr Pharma reported $1.72M in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
Alterity Therapeutics Limited AUD 43.68K 59.53K Dec/2025
Ardelyx USD 203.52M 683K Mar/2026
aTyr Pharma USD 1.72M 10.79M Mar/2026
Biogen USD 7.29B 1B Jun/2026
Bristol-Myers Squibb USD 42.09B 59M Jun/2026
Cipla INR 3.82B 840.2M Mar/2026
Clal Biotechnology ILS 25.96M 18.48M Dec/2023
Compugen USD 0 0 Dec/2024
CSL USD 10.42B 273M Dec/2025
Curis USD 29.43M 10.69M Jun/2024
GlaxoSmithKline GBP 13.95B 65M Jun/2026
Grifols EUR 9.95B 722.93M Dec/2025
Lakefront Biotherapeutics EUR 4.85M 335K Mar/2026
Novartis USD 37.49B 42M Jun/2026
Roche Holding CHF 25.22B 2.21B Jun/2026
United Therapeutics USD 100M 100M Jun/2024